PRIMECAP MANAGEMENT CO/CA/ – Allogene Therapeutics, Inc. Transaction History
PRIMECAP MANAGEMENT CO/CA/ portfolio value:
$52.84M
portfolio value
PRIMECAP MANAGEMENT CO/CA/ quarter portfolio value change:
-5.26%
quarter
Allogene Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.20% | 9.9K shares | -2.82M | $10.8 | 4.89M |
| Q2 2022 | share | Decrease | -0.47% | -23.3K shares | 10.97M | $11.4 | 4.88M |
| Q1 2022 | share | Increase | +5.24% | 244.45K shares | -24.85M | $9.11 | 4.90M |
| Q4 2021 | share | Increase | +29.34% | 1.05M shares | -23.07M | $15.38 | 4.66M |
| Q3 2021 | share | Increase | +0.76% | 27.27K shares | -658K | $25.7 | 3.60M |
| Q2 2021 | share | Increase | +174.02% | 2.27M shares | 47.20M | $26.08 | 3.57M |
| Q1 2021 | share | Increase | +5.41% | 67K shares | 14.82M | $35.3 | 1.30M |
| Q4 2020 | share | Increase | 0.00% | 1.23M shares | 31.25M | $25.24 | 1.23M |